News
After losing Roche as a partner, Blueprint Medicines has sold US commercial rights to RET inhibitor Gavreto to Rigel Pharma in a deal worth up to $117.5 million.
🤓 Nerdy Tip Kabbage rebranded to American Express Business Blueprintâ„¢ in February 2023. Business Blueprint includes the American Express® Business Line of Credit, among other products.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback